Study of lung disease in people with FLNA gene changes
Part of Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how changes in the FLNA gene affect lung health. If you have an FLNA mutation and lung problems, your participation may help researchers learn more about this condition and how to manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a change (mutation) in the FLNA gene
- You are willing to give written consent to join
- You have health insurance (social security coverage)
- You are able to participate in the entire study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific lung cells (called alveolar cells) to understand how smoking and chronic lung disease may change them. You may be invited if you are having lung surgery and can safely take part.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This trial looks at the “molecular landscape,” meaning the specific gene changes driving your lung cancer, for people whose non-small cell lung cancer (NSCLC) has rare mutations. The goal is to better understand what those rare changes mean and how they could guide treatment decisions.
This study looks at cells from the lungs of people who developed lung inflammation after chest radiation for cancer. It aims to understand why some people get this reaction, which may help find better treatments.
This study follows people who have a confirmed harmful (pathogenic) mutation in the LMNA and/or EMD gene. It aims to better understand these conditions through regular follow-up and health information collection, which may help improve future care.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
Hear when a new Emphysema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.